Freestone Capital Holdings, LLC Moderna, Inc. Transaction History

Freestone Capital Holdings, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $476,254 - $777,187	-2,109 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $467,987 - $1.02 Million	2,109 New	2,109 $315,000
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $263,123 - $448,211	-2,410 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $148,572 - $383,883	2,260 Added 1506.67%	2,410 $117 Million
Q3 2020 Nov 06, 2020	BUY	$54.34 - $94.85 $8,151 - $14,227	150 New	150 $10,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Freestone Capital Holdings, LLC with notifications on news.